KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Current Taxes: 2015-2024

Historic Current Taxes for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Dec 2024 value amounting to $451,000.

  • CRISPR Therapeutics AG's Current Taxes rose 308.83% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 308.83%. This contributed to the annual value of $451,000 for FY2024, which is 2.97% up from last year.
  • According to the latest figures from FY2024, CRISPR Therapeutics AG's Current Taxes is $451,000, which was up 2.97% from $438,000 recorded in FY2023.
  • In the past 5 years, CRISPR Therapeutics AG's Current Taxes registered a high of $10.5 million during FY2020, and its lowest value of $135,000 during FY2022.
  • Over the past 3 years, CRISPR Therapeutics AG's median Current Taxes value was $438,000 (recorded in 2023), while the average stood at $341,333.
  • Per our database at Business Quant, CRISPR Therapeutics AG's Current Taxes soared by 1,696.40% in 2020 and then slumped by 93.09% in 2021.
  • Yearly analysis of 5 years shows CRISPR Therapeutics AG's Current Taxes stood at $10.5 million in 2020, then tumbled by 93.09% to $724,000 in 2021, then plummeted by 81.35% to $135,000 in 2022, then spiked by 224.44% to $438,000 in 2023, then climbed by 2.97% to $451,000 in 2024.